CLGN Kapitalisasi Akuntansi CollPlant Ltd

This daily price chart for CollPlant Biotechnologies (CLGN) reflects the asset's dynamics, with a value of 0.00. Business growth is driven by pharmaceutical sector partnerships and the control of research expenditures. The project's success is based on the integration of plant-based proteins into filler production and the precision of regenerative methods. Profitability is sustained by the supply of 3D tissue printing materials to aesthetic and orthopedic centers.

As a leader in the production of plant-based collagen for 3D bioprinting, CollPlant Biotechnologies (CLGN) drives business value by capitalizing on its technological assets. By analyzing the organization's balance sheet capital, an investor assesses the difference between all assets and liabilities, which reveals the real value of equity accounting for tax effects and determines the extent of the asset's premium.